Skip to main content
Top of the Page
ABT

Reports and Publications

Industry-leading analysis. 

Access AusBiotech’s reports, publications and position papers offering in-depth analysis, industry insights, and policy perspectives on Australia’s life sciences sector.

21.05.26

Life Sciences in Australia: Industry Capability Report 2026

AusBiotech and the Australian Trade and Investment Commission (Austrade) have today jointly released two reports highlighting the scale, deep capability and global connectivity of Australia’s life sciences sector.

Read more →
21.05.26

Life Sciences in Australia: A National Network Driving Innovation 2026

AusBiotech and the Australian Trade and Investment Commission (Austrade) have today jointly released two reports highlighting the scale, deep capability and global connectivity of Australia’s life sciences sector.

Read more →
20.05.26

The Australian Medical Device Regulatory Scheme: Implementing Recommendations for Reform 2026

This document provides an overview of work being undertaken by AusBiotech and its members to support enhancements to the Australian Medical Device Regulatory Scheme.

Read more →
14.05.26

Australasian Biotechnology Journal Vol 36 No 1

The pace of innovation across Australia’s life sciences sector continues to accelerate, driven not only by breakthrough discoveries, but also by the increasingly powerful convergence of disciplines that were once considered distinct.

Read more →
01.08.25

AusBiotech Annual Report 2025

Australia’s life sciences sector is extraordinary. Every day, the scientists, researchers, clinicians, innovators and entrepreneurs who make up our sector contribute solutions to some of the world’s most complex health challenges.

Read more →
01.04.24

National Biotech and Medtech Development Commercialisation Summit 2024

AusBiotech and MTPConnect are delighted to deliver Australia’s first National Biotech and Medtech Development and Commercialisation Summit.

Read more →
01.10.23

Deloitte Economic Impact of the Research and Development Tax Incentive for the Biotech Industry 2023

The Australian biotech industry is a dynamic and rapidly growing sector. Biotech includes the use of living organisms, molecular and synthetic biology to produce healthcare products, therapeutics, diagnostics, and devices.

Read more →
01.08.23

US Investment in Australian Life Sciences Snapshot 2023

The US Investment in Australian Life Sciences Snapshot 2023 (US Investment Snapshot) was commissioned by AusBiotech to quantify the amount of US-originated capital flowing into the sector.

Read more →
01.07.23

National Cell and Gene Manufacturing Blueprint 2023

AusBiotech is pleased to present the National Blueprint for Cell and Gene (C&G) Manufacturing, outlining how, with a united and coordinated plan, Australia can realise the potential of its cell and gene (C&G) manufacturing future.

Read more →
01.01.23

A Practical Guide to ESG for Australian Life Sciences Companies 2023

AusBiotech is pleased to present the inaugural ESG Guide for Australian life sciences companies, with input from individuals and organisations across Australia’s diverse life sciences industry.

Read more →
01.10.22

Australian Biotechnology Sector Snapshot 2022

The Sector Snapshot 2022 (the Snapshot) was commissioned by AusBiotech to provide both an overview of the sector in Australia, in terms of organisation and employment numbers, and to determine how the sector has changed.

Read more →
01.10.22

Australia's Regenerative Medicines Investment Database 2021

In Australia, the signs point to increasing interest amongst investors in investing in regenerative medicine (RM) with $394.1m invested in 2020, compared with just $184.7m in 2019, a 113% increase in funding.

Read more →
01.10.22

Accelerating Health and Medical Research Commercialisation in Australia Main Report 2022

This project is a joint initiative between The University of Sydney, Faculty of Medicine and Heath (FMH), The University of Sydney Business School, and AusBiotech.

Read more →
01.10.22

Research Commercialisation in Australia Companion Report 2022

In 2021 The University of Sydney, Faculty of Medicine and Heath (FMH), The University of Sydney Business School, and AusBiotech commenced a project to develop a global gold standard framework to improve translation and commercialisation.

Read more →
01.09.21

Australia's Regenerative Medicine Global Pipeline Tracker 2021

This Australia’s Regenerative Medicine Clinical Trials Database project was conducted between September 2020 and June 2021 as a key part of the Regenerative Medicine Catalyst Project.

Read more →
01.09.21

Australia's Regenerative Medicine Clinical Trials Database (Global Data) 2021

This Australia’s Regenerative Medicine Clinical Trials Database project was conducted between September 2020 and June 2021 as a key part of the Regenerative Medicine Catalyst Project.

Read more →
01.09.21

The Regenerative Medicine Value Chain 2021

Regenerative medicine (RM) promises to deliver ground-breaking therapies to Australian patients, with innovative approaches targeting a wide range of conditions including rare genetic diseases, cancers, chronic diseases, and organ damage.

Read more →
01.09.21

Regenerative Medicine in Australia: Strategic Roadmap for the Regenerative Medicine Sector 2021

This Catalysing Regenerative Medicine in Australia, Strategic Roadmap was completed between September 2020 and September 2021 as a key part of the Regenerative Medicine Catalyst Project.

Read more →
01.09.21

Australia's Regenerative Medicine Therapies: Case Studies 2021

This Australian Regenerative Medicine Therapies project was conducted between September 2020 and September 2021 as a key part of the Regenerative Medicine Catalyst Project.

Read more →
01.09.21

Australia’s Regenerative Medicine Catalyst Body Funding & Model Structure 2021

The Regenerative Medicine Catalyst Project has brought together seven partners in a consortium to build the foundations for a national regenerative medicines (RM) sector ‘catalyst’ collaboration body.

Read more →
01.09.21

Australia's Regenerative Medicine Manufacturing Capacity and Capability 2021

Regenerative Medicine (RM) represents the possibility of revolutionary, lifelong, and curative therapies to meet some of the most pressing unmet medical needs.

Read more →
01.09.19

Australia's Life Sciences Sector Snapshot 2019

The Sector Snapshot 2019 (the Snapshot) was commissioned by AusBiotech to provide both an overview of the sector in Australia, in terms of organisation and employment numbers, and to determine how the sector has changed since 2017.

Read more →

Explore the Insights That Matter

AusBiotech powers BiotechDispatch, an independent twice weekly news source and website sharing the latest updates from across Australia’s biotech, medtech and digital health landscape.

Back to Top

We’ll keep you up to date with the latest

To join our mailing list, simply email.

[email protected] →
© 2025 AusBiotech. All rights reserved.
Connect with us